News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Epimab Biotherapeutics and Almirall Announce a License Agreement for Bispecific Antibodies
Saturday, October 14, 2023EpimAb Biotherapeutics a clinicalstage biopharmaceutical company specializing in the development of multispecific antibodies
Mimivax Has Been Granted Fast Track Designation by the Fda for Survaxm in the Management of Newly Diagnosed Glioblastoma
Friday, October 13, 2023MimiVax a biotechnology company specializing in glioblastoma vaccine therapy development recently announced that the United States Food and Drug Administration FDA
AGC Biologics Successfully Expands its pDNA and mRNA Production Lines in Heidelberg
Friday, October 13, 2023AGC Biologics a prominent global Contract Development and Manufacturing Organization CDMO specializing in the biopharmaceutical industry
Kanvas Biosciences Enhances Operations Through Acquisition of Federation Bio Assets to Advance Research, Development, and Production of Microbiome-based Therapeutics
Thursday, October 12, 2023Kanvas Biosciences a company specializing in microbiome mapping technology has announced its acquisition of two active therapeutics programs a microbial library and intellectual property from Federation Bio a manufacturer of live biotherapeutics prod...
Oxford Biotherapeutics Relocates Its UK Base to the Oxford Science Park, Aiming to Accelerate the Development of Immuno-oncology and ADC-based Cancer Treatments
Thursday, October 12, 2023Oxford BioTherapeutics Ltd OBT a clinicalstage oncology company specializing in immunooncology and antibodydrug conjugate ADCbased therapies has relocated its UK headquarters to The Schrodinger Building within The Oxford Science Park
Salipro Biotech and Icosagen Announce a Collaboration for Antibody Discovery
Wednesday, October 11, 2023Salipro Biotech AB a Swedish biotech company and Icosagen an Estonian biotechnology company have recently announced their collaboration in a multitarget antibody research agreement aimed at advancing drug discovery programs focused on challenging mem...
Scorpion Therapeutics and Pierre Fabre Laboratories Initiate Phase 1/2 Clinical Trial
Wednesday, October 11, 2023Scorpion Therapeutics Inc and Pierre Fabre Laboratories have jointly announced the commencement of a Phase clinical trial for STX a groundbreaking tyrosine kinase inhibitor tailored to target epidermal growth factor receptor EGFR and ERBB HER Exon...
Valo Therapeutics Acquires Bruker Corporation's Latest Mass Spectrometer Platform for Tumor Antigen Identification Through Valotx's Peptichip Technology
Wednesday, October 11, 2023Valo Therapeutics Oy ValoTx has made a significant announcement as the first European biotech company to incorporate the Bruker Corporations cuttingedge timsTOF Ultra mass spectrometer and liquid chromatography platform into its operations
RAD Granted Approval for Phase 1 Clinical Trial of PDL1-Nanobody in Non-Small Cell Lung Cancer
Tuesday, October 10, 2023Radiopharm Theranostics ASXRAD has obtained approval from the Human Research Ethics Committee HREC to initiate its Phase I study in Australia marking the first human trials for the companys therapy designed to treat patients with PDLpositive nonsmall...
FDA Grants Orphan Drug Designation to Ultimovacs' UV1 Vaccine for Mesothelioma Treatment
Monday, October 09, 2023Ultimovacs ASA OSE ULTI a prominent biotechnology company specializing in innovative cancer vaccines has secured Orphan Drug Designation ODD from the US Food and Drug Administration FDA for their therapeutic cancer vaccine UV intended for the treatme...
